SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.
Humacyte announced positive interim results from its V012 Phase 3 study showing the acellular tissue engineered vessel (ATEV) achieved superior catheter-free days (91 more days, p=…
KIDZ AI Inc. has filed a certificate of amendment with the SEC, modifying its corporate governance documents. The filing indicates potential changes to company structure or shareho…
Usio, Inc. filed amended and restated bylaws for its Nevada corporation, updating governance procedures for stockholder meetings and corporate operations. The changes reflect stand…
Sensei Biotherapeutics increased authorized Common Stock from an undisclosed prior amount to 300 million shares and authorized Preferred Stock at 10 million shares, totaling 310 mi…
Molina Healthcare of Illinois was selected by Illinois Department of Healthcare and Family Services for a HealthChoice Illinois Medicaid Managed Care contract covering approximatel…
Aethlon Medical reported fiscal year 2026 results and announced progression of its Australian oncology trial into Cohort 3, the final dosing phase, with the first participant treat…
Yelp's Board amended and restated its 2012 Employee Stock Purchase Plan, which was approved by stockholders on June 5, 2026. The plan provides equity incentives to retain employees…
U.S. Premium Beef, LLC filed an amended and restated limited liability company agreement effective through June 9, 2026, updating governance and operational provisions. The filing …
Masimo Corporation filed its Ninth Amended and Restated Certificate of Incorporation, establishing standard Delaware corporate governance provisions including director liability pr…
Rafael Holdings announced completion of its pivotal Phase 3 TransportNPC study evaluating Trappsol Cyclo for Niemann-Pick Disease Type C treatment, with 94 patients across 27 sites…
Cullinan Therapeutics reported encouraging Phase 1 clinical data for its CD19 and BCMA T cell engager programs targeting autoimmune diseases, with CLN-978 showing remissions in SLE…
InMed Pharmaceuticals has regained compliance with Nasdaq's minimum bid price requirement of $1.00 per share after its stock traded at or above that level for 10 consecutive busine…
The Federal Reserve Board will release results from its annual bank stress test on Wednesday, June 24, at 4 p.m. EDT. The stress test evaluates the capital adequacy and resilience …
The company's Board approved Amendment No. 1 to its 2021 Stock Plan on April 28, 2026, with stockholder approval on June 9, 2026. The amendment modifies the equity compensation fra…
Vistagen announced its fasedienol nasal spray program for social anxiety disorder has met international safety database exposure standards with over 1,500 subjects enrolled. The mi…
Ulta Beauty amended its Certificate of Incorporation to expand director and officer liability protections and establish Delaware courts as the exclusive forum for derivative action…
Super Micro Computer filed an 8-K highlighting potential conflicts of interest with related parties Ablecom and Compuware, which supplied 6.6% of cost of sales in fiscal 2023 and r…
Relay Therapeutics amended its certificate of incorporation to increase total authorized capital stock from an unstated prior amount to 460 million shares, comprising 450 million c…
Big Digital Energy amended its certificate of incorporation to eliminate the Series C Junior Participating Preferred Stock designation, converting 10,000 shares back to undesignate…
Shattuck Labs reported Phase 1 data for SL-325 showing a potentially best-in-mechanism immunogenicity profile with only 3.7% antidrug antibodies and complete TL1A blockade lasting …